MORGAN STANLEY PLC/PUT/MERCK & CO./125/0.1/20.09.24 Share Price

Warrant

DE000ME85TQ9

Real-time Bid/Ask 13:42:19 28/06/2024 BST
0.27 EUR / 0.29 EUR -6.67% Intraday chart for MORGAN STANLEY PLC/PUT/MERCK & CO./125/0.1/20.09.24
Current month-37.50%
3 months-21.05%
Date Price Change
28/06/24 0.26 -13.33%
27/06/24 0.3 +47.06%
26/06/24 0.204 0.00%
25/06/24 0.204 -0.97%
24/06/24 0.206 -23.70%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 09:50 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME85TQ
ISINDE000ME85TQ9
Date issued 05/02/2024
Strike 125 $
Maturity 20/09/2024 (84 Days)
Parity 10 : 1
Emission price 0.66
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.82
Lowest since issue 0.186
Delta-0.32x
Omega 13.69
Premium6.06x
Gearing42.54x
Moneyness 0.9629
Difference Strike -4.82 $
Difference Strike %-3.86%
Spread 0.03
Spread %10.00%
Theoretical value 0.2850
Implied Volatility 22.14 %
Total Loss Probability 64.16 %
Intrinsic value 0.000000
Present value 0.2850
Break even 121.95 €
Theta-0.02x
Vega0.02x
Rho-0.01x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.8 USD
Average target price
142.7 USD
Spread / Average Target
+9.91%
Consensus